---

---

crawled date : 2020 - 12 - 01    crawled time : 22:00   

save search

---

Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
OTLK | News P | $8.2 1.36% 1.34% 150K |

Health Technology

| 583.33% | O: 1.67% H: 2.46% C: -5.74%
therapeutics nasdaq

---

Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
MBRX | $4.6 6.98% 3.37% 7.4K |

Health Technology

| -1.71% | O: 41.03% H: 10.91% C: -10.0%
disease fda wp1066 approval fda approval designation rare

---

Cidara Therapeutics to Present Preclinical Data for Influenza AVCs at the 7th ESWI Influenza Conference
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
CDTX | News | $10.25 -0.27% -1899.22% 1.9M |

Health Technology

| -78.21% | O: 2.14% H: 0.0% C: -9.21%
influenza preclinical pre-clinical

---

Cytokinetics Announces Additional Results From GALACTIC-HF to be Presented at the 17th Global Cardiovascular Clinical Trialists ForumData from Supplemental Analyses to be Shared at Clinical Trials Think Tank Meeting
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
CYTK | $65.57 -1.09% -1.11% 1.3M |

Health Technology

| 290.3% | O: 1.19% H: 5.53% C: 3.18%
results cardio cardiovascular trial

---

Model N to Present at Upcoming Raymond James Technology Investors Conference
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
MODN | $29.65 0.3% -0.47% 1.1M |

Technology Services

| -13.96% | O: 0.99% H: 0.0% C: -2.18%

---

AbbVie to Host Virtual Immunology Strategic Update
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| 62.12% | O: 0.45% H: 1.27% C: -0.96%
immunology

---

Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
APDN | $0.29 -12.12% -14.27% 800K |

Commercial Services

| -96.14% | O: -0.66% H: 0.0% C: -3.88%
covid test covid-19

---

Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
PBLA | News | $0.42 -11.54% -6.31% 64K |

Professional, Scientific, and T...

| -87.79% | O: -2.33% H: 3.87% C: 2.68%
biopharma therapeutics

---

Zimmer Biomet Completes Acquisition of A&E Medical Corporation
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
ZBH | $121.52 0.61% 0.17% 740K |

Health Technology

| -18.51% | O: 0.92% H: 0.29% C: -2.92%
acquisition

---

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
ECOR | $5.66 0.71% 4.75% 7.3K |

Health Technology

| 277.33% | O: 1.33% H: 10.66% C: 4.61%
drug opioid

---

Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
BLPH | $0.0586 14.68% -45.37% 15M |

Health Technology

| -99.16% | O: 1.12% H: 1.38% C: -6.63%
disease phase 3 treatment enroll

---

BioCardia Reports Published Study Showing Helix Biotherapeutic Delivery System Used in CardiAMP Phase III Heart Failure Trial Has Fewest Adverse Events Among Competitive Delivery Systems
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
BCDA P | $0.376 2.23% -2.56% 80K |

Health Technology

| -83.83% | O: 0.85% H: 5.06% C: 4.22%
heart liver trial cardiamp system study

---

Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
RDY | $71.49 -0.92% 0.0% 130K |

Health Technology

| 9.0% | O: -0.26% H: 0.75% C: 0.64%
india vaccine trial

---

Athira Pharma Announces Initiation of Patient Dosing for ACT-AD Clinical Trial of ATH-1017, Small Molecule HGF/MET Activator, for Treatment of Mild-to-Moderate Alzheimer’s Disease
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
ATHA | $2.04 -2.39% -2.7% 83K |

Health Technology

| -91.81% | O: 0.72% H: 0.92% C: -5.14%
disease alzheimer trial treatment ath-1017 alzheimer’s alzheimer's disease alzheimer's

---

Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with BalstilimabNew objective response in colon cancer triggers trial expansion
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
AGEN A | $6.46 11.96% 10.4% 1.6M |

Health Technology

| 74.59% | O: 0.81% H: 7.51% C: 1.88%
cancer trial expansion phase 2

---

BioLife Solutions & Casdin Capital Innovation Accelerator Announce New Investments in Cell & Gene Therapy Bioproduction Tools
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
BLFS S | $17.02 1.31% 1.18% 530K |

Health Technology

| -52.71% | O: 0.86% H: 0.08% C: -3.61%
therapy gene therapy gene therapies

---

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
ANIX | $3.07 1.99% 1.63% 72K |

Health Technology

| 16.29% | O: 4.17% H: 7.27% C: 4.36%
license cancer vaccine ovarian cancer bioscience

---

Gainers vs Losers

77%

23%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 26M |

AGBA | $2.97 137.6% 57.48% 66M |

Finance

EDBL | News | $6.59 75.27% 41.8% 2M |

ZAPP | $4.44 50.2% 33.12% 370K |

n/a

MTC | $2.24 43.59% 30.67% 6M |

Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M |

Finance

SHIM | $3.045 35.33% 26.23% 870K |

HKIT | $1.33 30.39% 24.16% 390K |

Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M |

Wholesale Trade

OST | $0.5 25.0% 21.88% 280K |

---

Your saved searches

---